Xiumei Cai

Person

Shanghai, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Immunologic effector cell of targeted CLD18A2, and preparation meth...
- Patent number 12,098,199
- Issue date Sep 24, 2024
- CRAGE medical Co., Limited
- Huamao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polypeptide and antibody bound to polypeptide
- Patent number 11,479,603
- Issue date Oct 25, 2022
- Shanghai Yile Biotechnology Co., Ltd.
- Xiumei Cai
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
GPC3 and ASGPR1 double-targeted transgenic immune effector cell and...
- Patent number 11,453,860
- Issue date Sep 27, 2022
- CRAGE Medical Co., Limited
- Huamao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunologic effector cell of targeted CLD18A2, and preparation meth...
- Patent number 11,198,729
- Issue date Dec 14, 2021
- CAFA THERAPEUTICS LIMITED
- Huamao Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Binding molecule that binds specifically to the precursor of brain-...
- Patent number 10,556,947
- Issue date Feb 11, 2020
- Shanghai Yile Biotechnology Co., Ltd.
- Changqi Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunologic effector cell of targeted CLD18A2, and preparation meth...
- Patent number 10,377,822
- Issue date Aug 13, 2019
- CARsgen Therapeutics LTD.
- Huamao Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
IMMUNOLOGIC EFFECTOR CELL OF TARGETED CLD18A2, AND PREPARATION METH...
- Publication number 20220363751
- Publication date Nov 17, 2022
- CAFA THERAPEUTICS LIMITED
- Huamao WANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF PROBDNF REGULATOR IN B CELL-RELATED DISEASES
- Publication number 20220064274
- Publication date Mar 3, 2022
- SHANGHAI YILE BIOTECHNOLOGY CO., LTD.
- Ruping DAI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYPEPTIDE AND ANTIBODY BOUND TO POLYPEPTIDE
- Publication number 20210061896
- Publication date Mar 4, 2021
- SHANGHAI YILE BIOTECHNOLOGY CO., LTD.
- Xiumei CAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF BINDING MOLECULE SPECIFICALLY BINDING TO PRECURSOR OF BRAIN-...
- Publication number 20210017264
- Publication date Jan 21, 2021
- SHANGHAI YILE BIOTECHNOLOGY CO., LTD.
- Changqi LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOLOGIC EFFECTOR CELL OF TARGETED CLD18A2, AND PREPARATION METH...
- Publication number 20200172613
- Publication date Jun 4, 2020
- CARSGEN THERAPEUTICS LTD.
- Huamao Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GPC3 AND ASGPR1 DOUBLE-TARGETED TRANSGENIC IMMUNE EFFECTOR CELL AND...
- Publication number 20180201902
- Publication date Jul 19, 2018
- CARSGEN THERAPEUTICS LTD.
- HUAMAO WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF BINDING MOLECULE SPECIFICALLY BINDING TO PRECURSOR OF BRAIN-...
- Publication number 20170362313
- Publication date Dec 21, 2017
- Changqi Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOLOGIC EFFECTOR CELL OF TARGETED CLD18A2, AND PREPARATION METH...
- Publication number 20170204177
- Publication date Jul 20, 2017
- CARSGEN THERAPEUTICS LTD.
- Huamao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Immunologic effector cell of targeted CLD18A2, and preparation meth...

Polypeptide and antibody bound to polypeptide

GPC3 and ASGPR1 double-targeted transgenic immune effector cell and...

Immunologic effector cell of targeted CLD18A2, and preparation meth...

Binding molecule that binds specifically to the precursor of brain-...

Immunologic effector cell of targeted CLD18A2, and preparation meth...

Patents Applicationslast 30 patents

IMMUNOLOGIC EFFECTOR CELL OF TARGETED CLD18A2, AND PREPARATION METH...

USE OF PROBDNF REGULATOR IN B CELL-RELATED DISEASES

POLYPEPTIDE AND ANTIBODY BOUND TO POLYPEPTIDE

USE OF BINDING MOLECULE SPECIFICALLY BINDING TO PRECURSOR OF BRAIN-...

IMMUNOLOGIC EFFECTOR CELL OF TARGETED CLD18A2, AND PREPARATION METH...

GPC3 AND ASGPR1 DOUBLE-TARGETED TRANSGENIC IMMUNE EFFECTOR CELL AND...

USE OF BINDING MOLECULE SPECIFICALLY BINDING TO PRECURSOR OF BRAIN-...

IMMUNOLOGIC EFFECTOR CELL OF TARGETED CLD18A2, AND PREPARATION METH...